1. Bachaud JM, Shubinski R, Boussin G et al. (1992) Stage I cutaneous malignant melanoma: risk factors of loco-regional recurrence after wide local excision and clinical perspectives. Eur J Surg Oncol 18: 442–448
2. Balch CM, Soong Sj, Shaw HM, Milton GW (1992) An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong S (eds) Cutaneous melanoma. Lippin-cott, Philadelphia, pp 321–352
3. Böttcher HD, Kaufmann R (Hrsg) (1999) Klinik des metas-tasierten Malignen Melanoms: Grundlagen, Diagnostik, Therapie. Zuckschwerdt
4. Farthmann B, Eberle J, Krasagakis K et al. (1998) RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol 110:263–267
5. Garbe C (1993) Schwangerschaft, Hormonpräparate und malignes Melanom. Hautarzt 44:347–352